Argos Therapeutics Publishes Novel Approach to Improving Stimulation of Immunotherapeutic Pathways via Dendritic Cells

Argos Therapeutics today announced the publication of an article in the online journal BMC Molecular Biology supporting the Company┬┤s novel method of stimulating the CD40 receptor signal cascade in dendritic cells (DCs), which may potentially improve the p... [more]

View complete Press Release article